GlassScriptPhysician profile
Allison Giddings Jackson
NPI 1194929588
$444.36
in general payments reported to CMS, 2019-2025
11 companies · $22.16 in 2025
The $22.16 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.71 · 2021: $24.93 · 2022: $101 · 2023: $241 · 2024: $25.35 · 2025: $22.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $121.66 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $73.33 | 2020-2023 | Invega Sustenna |
| Pfizer INC. | $49.20 | 2022-2023 | |
| Myovant Sciences INC. | $45.06 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.99 | 2022-2023 | |
| Exact Sciences Corporation | $28.01 | 2023-2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $22.16 | 2025 | Injectafer |
| Mayne Pharma Commercial LLC | $20.48 | 2023 | |
| Sumitomo Pharma America, INC. | $19.53 | 2023 | Myfembree |
| Coopersurgical, INC. | $14.45 | 2022 | |
| Organon LLC | $10.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.